跳至主要内容
临床试验/NCT03232502
NCT03232502Unknown3 期

Pharmacogenetics in Primary Care Psychotropics

University of Arizona0 个研究点目标入组 130 人开始时间: 2017年8月15日最近更新:
适应症

试验速览

阶段
3 期
入组人数
130
主要终点
Patient oriented outcome1- Clinical Improvement

研究概览

简要总结

Pragmatic trial of pharmacogenetic testing at the time of prescription for a selective serotonin reuptake inhibitor, tricyclic antidepressant or atypical antipsychotic. Does real time intervention improve patient outcomes?

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Prescribed a drug of interest for the first time

排除标准

  • Previous pharmacogenetic testing available

结局指标

主要结局

Patient oriented outcome1- Clinical Improvement

时间窗: 6 months

Clinically significant improvement as noted by physician (Subjective and PHQ-9)

Patient oriented outcome2- Adverse effects

时间窗: 6 months

Number of patients with specific, common side effects (from medical chart)

Patient oriented outcome3- Time to Improvement

时间窗: Up to 6 months

Days to clinical improvement (from medical chart)

Patient oriented outcome5- Visits

时间窗: 6 months

Total number of visits to clinic with medication titration required (from medical chart)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验

Pharmacogenetics in Primary Care Psychotropics | 临床试验